In girls with gonadotropin-independent precocious puberty, aromatase inhibitors such as letrozole are often employed to suppress estrogen production and delay epiphyseal closure, helping to maximize adult height and reduce the risk of early-onset skeletal complications [60]. The gene discussed is CYP19A1; the disease is precocious puberty.